SEELOS THERAPEUTICS INC (SEEL)
US81577F3073 - Common Stock
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 4.09M | -37.88M | -73.53M | -66.05M | -19.10M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 12.76M | 12.42M | 2.78M | -1.41M | -4.54M | |||
| Interest Paid | 414.00K | 505.00K | 11.00K | 10.00K | 11.00K | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | -30.12M | 1.55M | 9.15M | 18.46M | 2.73M | |||
| OPERATING CASH FLOW | -13.27M | -23.91M | -61.60M | -48.99M | -20.91M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -5.54M | -7.64M | -1.89M | -13.55M | 11.05M | |||
| Stock Issued/Repurchased | 13.27M | 19.02M | 564.00K | 125.62M | 15.26M | |||
| Other Financing Activity | N/A | N/A | -273.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 7.72M | 11.38M | -1.60M | 112.07M | 26.31M | |||
| CHANGE IN CASH | -5.55M | -12.54M | -63.20M | 63.07M | 5.40M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.27M | -23.91M | -61.60M | -48.99M | -20.91M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -13.27M | -23.91M | -61.60M | -48.99M | -20.91M | |||
All data in USD